LINC02753

Across TCGA pan-cancer cohorts, LINC02753 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated LINC02753 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher LINC02753 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02753 expression acts as an unfavorable survival marker, although some lineages such as ESCA and COAD show a favorable association.

READ, ESCA, and CHOL are the cancer types where LINC02753 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	IV	0.055	0.646	<.001	45	view →
ESCA	DFS	Median	All	0.401	0.226	.007	15	view →
CHOL	OS	Tertile	All	0.134	0.664	.019	15	view →
GBM	OS	Tertile	All	0.175	0.423	.003	9	view →
TGCT	DFS	Tertile	All	0.281	0.717	.009	6	view →
BRCA	DFS	Median	IV	0.370	0.684	.036	5	view →
COAD	DFS	Tertile	II,III,IV	0.767	0.604	.042	3	view →
PAAD	DFS	Quartile	All	0.193	0.348	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

LINC02753–READ (DFS)

Open the READ breakdown →